Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunic (DE:10VA)
BERLIN:10VA
Immunic (10VA) Stock Price & Analysis
1 Followers
10VA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.89 - €2.67
Previous Close€1.16
Volume0.00
Average Volume (3M)3.01K
Market Cap
€102.68M
Enterprise Value€59.69M
Total Cash (Recent Filing)$46.67M
Total Debt (Recent Filing)$639.00K
Price to Earnings (P/E)N/A
Beta0.71
Next Earnings
May 09, 2024EPS Estimate
-€0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,929,016
10 Day Avg. Volume0
30 Day Avg. Volume3,010
Standard Deviation0.10
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)3.79
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.64
Forecast
1Y Price Target
€10.95Price Target Upside843.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Immunic News
PremiumCompany Announcements
Immunic, Inc. Is Worried About This – Should You Be Worried Too?Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.06% Other Institutional Investors
99.94% Public Companies and
Individual Investors
10VA FAQ
What was Immunic’s price range in the past 12 months?
Immunic lowest stock price was €0.89 and its highest was €2.67 in the past 12 months.
What is Immunic’s market cap?
Currently, no data Available
When is Immunic’s upcoming earnings report date?
Immunic’s upcoming earnings report date is May 09, 2024 which is in 9 days.
How were Immunic’s earnings last quarter?
Immunic released its earnings results on Feb 22, 2024. The company reported -€0.448 earnings per share for the quarter, beating the consensus estimate of -€0.478 by €0.03.
Is Immunic overvalued?
According to Wall Street analysts Immunic’s price is currently Undervalued.
Does Immunic pay dividends?
Immunic does not currently pay dividends.
What is Immunic’s EPS estimate?
Immunic’s EPS estimate is -€0.24.
How many shares outstanding does Immunic have?
Currently, no data Available
What happened to Immunic’s price movement after its last earnings report?
Immunic reported an EPS of -€0.448 in its last earnings report, beating expectations of -€0.478. Following the earnings report the stock price went down -1.583%.
Which hedge fund is a major shareholder of Immunic?
Among the largest hedge funds holding Immunic’s share is Omega Fund Management, LLC. It holds Immunic’s shares valued at 3M.
---
Immunic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€10.95 (843.45% Upside)
€10.95 (843.45% Upside)
Blogger Sentiment
Bullish
DE:10VA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $18.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.15%
12-Months-Change
Fundamentals
Return on Equity
-131.28%
Trailing 12-Months
Asset Growth
-57.50%
Trailing 12-Months
Company Description
Immunic
Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
---
10VA Company Deck
---
10VA Earnings Call
Q4 2024
0:00 / 0:00
---
10VA Stock 12 Months Forecast
Average Price Target
€10.95
▲(843.45% Upside)
Technical Analysis
Best Analysts Covering 10VA
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-21.33%
reiterated a buy rating 2 months ago
Copying Andreas Argyrides's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -21.33% per trade.
---